NASDAQ:SWAV
Delisted

Shockwave Medical Stock News

etoro logo Buy SWAV
*Your capital is at risk
$334.75
+0 (+0%)
At Close: Aug 29, 2024
ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q1 2021 Results - Earnings Call Transcript
Shockwave Medical (SWAV) delivered earnings and revenue surprises of -61.90% and 1.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Recap: ShockWave Medical Q1 Earnings

05:22pm, Monday, 10'th May 2021
Shares of ShockWave Medical (NASDAQ:SWAV) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 15.25% year over year to ($0.68), which missed
SANTA CLARA, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex cal
The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

ShockWave Medical's Earnings Outlook

10:08am, Friday, 07'th May 2021
ShockWave Medical (NASDAQ:SWAV) releases its next round of earnings this Monday, May 10. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule
SANTA CLARA, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascul
SANTA CLARA, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex c
Which of these amazing medical technology companies is better for your portfolio for the next decade?

Why ShockWave Medical Stock Is Soaring Today

01:12pm, Tuesday, 30'th Mar 2021
The company announced preliminary first-quarter results.
The stock price of Shockwave Medical, Inc. (NASDAQ: SWAV) increased by over 10% pre-market. This is why it happened.
The medical-device maker needs to keep its foot on the revenue gas.
Hint: Focus on the business, not the stock.
ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q4 2020 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE